Skip to main content
. 2023 Feb 14;15(4):1212. doi: 10.3390/cancers15041212

Figure 2.

Figure 2

Median OS was 30.7 months (95%CI 27.8 to 101) in patients with low CD44 expression (blue line, dashed) versus 14.5 months (95%CI 11.7 to 35.9) in high CD44 expression group (green line, continuous) (p = 0.0001). The proportion of patients alive at 24 months was 70% in the low CD44 expression group versus 21% of high CD44 expression patients (p = 0.0001).